SBIR Phase I.
Up to $700,000.
No equity. No repayment.
Non-dilutive funding for US small businesses that are proving if a new biomedical, healthcare, public-health or FDA-regulated product works. Register free and discover your fit before you write a word.
Named matches and indicative funding, with specialist support.
Is your company
a fit?
Phase I funds the R&D that proves a new biomedical, healthcare, public-health or FDA-regulated innovation works: experiments, prototypes, technical validation. It isn't for rollout, sales or market-ready products.
You don't need to know which institute or center you'd apply through. You do need a strong match with one area NIH, CDC or FDA covers, and the match decides what you get: $700,000 or $400,000 by NIH institute, $314,363 for CDC and FDA.
- US for-profit small business, 500 employees or fewer, majority US-owned and controlled.
- Genuine R&D to prove feasibility, with credible commercial potential.
- At least two-thirds of the research done by your own company.
- A lead researcher resident in the US and primarily employed by you.
- Mainly implementation, rollout, sales, marketing or routine product development.
- A university, CRO or external lab doing most of the research. That's STTR, not SBIR.
- Majority foreign-owned, or substantial R&D outside the US.
- An existing tool applied to a new customer segment.
From 'is it worth it?' to submitted, in weeks not months.
The Grantify platform handles structure and compliance. Our specialists make the judgment calls and review every submission.
Match
Register free, answer questions about your business and technology, and get a named match with an indicative funding value. Minutes, not weeks.
Plan
A 20-minute call with a specialist who has seen your answers: which institute or center to request, what reviewers score, and whether January 5 is your date.
Apply
Structured answers mapped to what peer reviewers assess, a specialist workshop on the research strategy, and a review before anything is submitted.
While January 5 is the deadline, November 24 is the date that matters.
A first-time applicant needs five federal registrations before NIH will take a submission, and each can take six weeks or more. Grantify's application window is 42 days. The realistic window to start is now.
Find out if SBIR Phase I
is yours to win.
Free registration. Named match and indicative funding in minutes. Deadline January 5; realistic start November 24.
Which institute should I apply to, and does it change how much I can ask for?
Yes, it changes the cap: seven NIH institutes allow up to $700,000, nine allow up to $400,000, and all CDC and FDA components allow up to $314,363. You can request an institute or center; the funder makes the final decision. Picking the right one to request is the first thing we work on with you.
Do I need to be a US citizen?
No. The company needs to be more than 50% owned and controlled by US citizens or permanent residents. Your lead researcher doesn't need to be a citizen either, but must legally reside in the US and be primarily employed by your company for the project.
Does my project need a clinical trial?
No, and projects without one are usually simpler to position. Projects with a trial can apply, with some excluded research areas, and need a Regulatory Plan and human-subjects documentation, which Grantify does not prepare within its standard fee.
What happens after Phase I?
A separate Phase II application continuing the R&D, typically over one to three years. NIH's standard guideline is around $2.15 million; some institutes allow up to around $3 million.
Is what I share with Grantify confidential?
Yes. Your technology and IP stay yours. Everything you share with Grantify is confidential, used only to assess and prepare your application.
What does Grantify cost?
Registration, matching and your first call with a specialist are free. If Phase I is a fit and you decide to apply, we'll set out exactly what's included and what it costs before you commit to anything.
Grantify is an independent grant consultancy and is not affiliated with, or endorsed by, the National Institutes of Health, the Centers for Disease Control and Prevention, the Food and Drug Administration or any US federal agency. The funder makes all award decisions. Meeting eligibility does not guarantee funding. Caps, dates and rules are taken from funding opportunity PA-27-100; the announcement on grants.gov is the authoritative source. Privacy Policy. Terms of Service. Copyright © 2026 Grantify, Inc.